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1. Introduction 
The cholesterol side-chain cleavage enzymesystem 
occurring in the adrenal cortex is able to convert 
cholesterol, 20o-OH cholesterol (20a)*, 22R-OH 
cholesterol (22R) and 2Ocu, 22R-d&OH cholesterol 
(2Oo, 22R) (inter alia) into pregnenolone and isocapro- 
aldehyde. According to the ‘classical scheme’ the 
reactions are: 
2oo 
cholesterol* ’ 
If 
20a, 22R + pregnenolone + 
22R 
isocaproaldehyde 
A direct conversion of cholesterol into 2Oo, 22R has 
also been proposed [ 1,2] . However evidence for two 
sequential mono-oxygenases or for a concerted attack 
of oxygen producing the dihydroxy cholesterol is 
still lacking. There are several other models of 
Abbreviations: HEPES, N-2-hydroxyethylpiperazine-N’-2- 
ethanesulfonic acid; Cyanoketone, 2a-cyano4,4,1 ‘lortrimethyl- 
17@-hydroxyandrost-S-en-3-one; Cholesterol, S-cholesten-3p-ol; 
Epi-cholesterol, S-cholesten-3a-ol; 20wOH cholesterol, 5-choles- 
ten-3p,20wdiol; 22R-OH cholesterol, (22R)-5-cholesten-3p,22- 
diol; 20o,22R-di-OH cholesterol, (22R)-5-cholesten-3p,20%22- 
triol; 20a,22S-di-OH cholesterol, (22S)-5-cholesten-3@,2Oo,22- 
trio]: A2’ -*’ cholesterol, 5,20(22)-cholestadien-3p-ol; 
20,22-epoxycholesterol, 20,22-epoxy-5-cholesten-3p-ol; 
Pregnenolone, 5-pregnen-3p-ol-20-one. 
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cholesterol side-chain cleavage which also lack good 
experimental evidence [3-51. 
We have studied the conversion of 22R into 
pregnenolone and isocaproaldehyde. In this paper the 
identity of the intermediate 20~5 22R will be 
established by a combination of gas chromatography 
and mass spectrometry. In addition we found that 
20a, 22R is not the only intermediate. The results 
strongly suggest 20,22-epoxycholesterol to be an 
intermediate in the same reaction. The experiments 
support our previously presented hypothesis, according 
to which 22R is converted into pregnenolone and 
isocaproaldehyde via A20-22 cholesterol, 20,22-epoxy- 
cholesterol and 20a, 22R-d&OH cholesterol [6]. 
2. Materials and methods 
Bovine adrenal cortex mitochondria were prepared 
according to standard procedures and stored directly 
in liquid nitrogen. Conversion of 22R-OH cholesterol 
into pregnenolone was estimated in a medium containing 
1.54 mM KCl, 11.5 mM NaCl, 50 mM nicotinamide, 
20 mM HEPES (pH 7.3), 5 mM CaC12, 4 mM sodium 
azide, 1% bovine serum albumin (w/v) with a final vol 
of 25 ml. Incubations were carried out at 37°C in a 
thermostatically controlled vessel, the contents of 
which were magnetically stirred. The above ‘freeze- 
damaged’ mitochondria (23 mg protein) were used. 
Additions were made to achieve a final concentration 
of 30 PM cyanoketone [7], 5 PM antimycin A, 
0.1 mM NADP, 3 mM glucose 6-phosphate and 
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0.6 U/ml glucose 6-phosphate dehydrogenase. 
After a 5 min preincubation at 37°C a sample was 
taken to correct for the pregnenolone formation from 
endogeneous cholesterol and 1300 nmol 22R-OH 
cholesterol (Ikapharm, Israel) were added to the 
medium. 
Exp. 1 -A: Every minute a 0.5 ml sample was taken 
and extracted with ice-cold ethylacetate. The first 
sample was taken 10 set after addition of 22R-OH 
cholesterol. 
Exp. 1 -B: Samples of 2 ml were taken from the sulne 
incubation at intervals as indicated in fig. 1 -B, added 
to 25 ml erlenmeyers and immediately flushed with 
100% carbonmonoxide (500 ml/min) for 120 sec. The 
contents were sealed off from air and incubated in a 
shaking incubator at 37’C for 20 min. Reactions were 
also stopped by cold ethylacetate. Since it took CO 
1 min. to stop 22R conversion and pregnenolone 
formation, the indicated time at the abscissa of fig. 1 -B 
is the time the sample was taken from the experiment 
(shown in fig. 1 -A) plus 1 minute. 
To all samples 20 pg/ml(50 PM) epi-cholesterol 
was added as an internal standard. Steroids were 
extracted with 3 X 6 ml distilled ethylacetate. The 
solvent was evaporated at room temperature with 
nitrogen. The extract was silylated and the steroids 
were quantified by gas chromatography as described 
[6]. All glassware had been cleaned with a potassium 
bichromate--sulfuric acid mixture and siliconized with 
Siliclad (Clay Adams). 
Gaschromatographic analysis (fig.2) was performed 
at 250°C on a capillary column coated with Se-30, 
length 60 m [8], with a solid state injector [9], 
equipped with a flame ionizing detector (full scale in 
fig.2 1 X lo- ” A) and with nitrogen as a carrier gas. 
The mass spectra were obtained by a CC-MS 
combination as described by Leferink et al. [lo] . The 
conditions were as follows: temperature of the column 
23O”C, CC-MS interface 26O”C, source 23O”C, 
accelerating voltage 4 KeV, ionizing voltage 70 eV and 
ionizing current 500 PA. 
Thin-layer chromatography was performed on 
silicagel (Merck 60 Fzs4) with pentane : ether : glacial 
acetic acid (60 : 40 : 2). 20a, 22S-di-OH cholesterol 
was synthesized according to Chaudhuri et al. [ 111 
using sodium borohydride reduction. Protein was 
estimated by the biuret method. 
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Fig.1. (A) Conversion of 22R-OH cholesterol into pregnenolon 
by damaged bovine adrenal cortex mitochondria supported 
by a NADPH-generating system. 20a, 22R is formed as an 
intermediate. The shaded area represents the apparent ‘mass- 
defect’. The steroids were quantified after trimethylsilylation 
by GLC. (B) Samples taken during the reaction of the 
experiment shown in fig.l(A) were immediately flushed with 
100% carbon monoxide (methods). They were incubated air- 
free in a shaking incubator at 37°C for 20 min. The shaded 
area decreases and 2Oa, 22R-OH cholesterol increases. The 
indicated time at the abscissa has been corrected for the time 
it took CO to stop the reaction (tl_B = tl_A + t min.). 
3. Results 
In fig.l-A it can be seen that 22R (1300 nmol) 
disappears in 10 min and 1300 nmol pregnenolone 
are formed. Assuming HOLY, 22R to be the only 
intermediate in the conversion from 22R into the 
products pregnenolone and isocaproaldehyde, the 
sum (nmol) of 22R, 20&, 22R and pregnenolone must 
be constant during the reaction. However the sum of 
the nmol substrate, intermediate and product is not 
constant. At t=4 min it is only 70% of the initial 
amount of substrate. Therefore 30% must be present 
in a form not detected by-our gaschromatographic 
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Fig.2. Gas-liquid chromatography of trimethylsilylated steroids on a capillary column (Metnoas): I) 2001, 22R-d&OH cholesterol, 
2) 200, 22S-d&OH cholesterol, 3) 20~OH cholesterol, 4) 22R-OH cholesterol, 5) cholesterol, 6) epi-cholesterol, 7) pregnenolone. 
method. The time course of formation and disappear- 
ance of this or these compounds is represented by the 
shaded area of fig. 1 -A. Analysis of the samples (taken 
from the experiment shown in fig. 1 -A), incubated for 
20 min under carbon monoxide (see Methods) and 
thus with complete inhibition of cytochrome P-450, 
shows a marked increase in 20~5 22R and a proportional 
decrease in the shaded area (fig. 1 -B). Apparently the 
compound(s) not measured by our method are in the 
presence of > 99% CO converted into ~OCX, 22R. 
Fig.2 shows a gas chromatogram obtained with a 
capillary column. The sample was taken at t=4 min 
(fig.]-B) and injected together with a mixture of 
pregnenolone, epi-cholesterol, cholesterol, 22R-OH 
cholesterol, 2Oc+OH cholesterol and 20q 22S-d&OH 
cholesterol. The biological intermediate 20q 22R is 
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clearly separated from the synthetically prepared 2001, 
22S-di-OH cholesterol, while the mass spectra of both 
compounds are almost identical (fig.3). 
Thin-layer chromatography (fig.4) of samples 
taken from an incubation analogous to the one shown 
in fig. 1 -A is in accord with the gaschromatographic 
analysis and supplements it. 22R decreases and 
pregnenolone is formed. Cholesterol from mitochondria 
origin is detected in all samples. However a compound 
with R,=0.37 is detectable during the reaction. It is 
neither present at the start of the reaction (t=O min) 
nor after the reaction has come to an end (t=l 1 min). 
Isolation of the unknown substance from thin-layer 
plates followed by silylation and gas chromatography 
showed the presence of a neglible amount of 2Oq 
22R as might be expected from the results, represented 
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Fig.4. Thin-layer chromatography of samples taken from an experiment analogous to the one described in fig.1. (A). Cholesterol of 
mitochondrial origin is present in all samples. At t=2, 5 and 8 min a spot with Rf;0,37 is visible, preliminarily identified as 20, 22- 
epoxycholesterol. 
by fig. 1 -A. Chemical hydrolysis with perchloric acid 
[ 121 converted the unknown compound into 20, 22- 
d&OH cholesterol. 
3.1. Discussion of the mass spectra 
The upper part of fig.3 is the mass-spectrum of 
persilylated 2Oq 22S-di-OH cholesterol. The molecular 
weight of the compound is 634. Characterisation of 
some important fragments demonstrates the location 
of the hydroxylgroups in the side-chain. 
The fragment at m/e 563 indicates a simple fission 
of the 22-23 bond, and loss of an additional (CH& 
Si-OH group produces a fragment at m/e 473. The 
peaks at m/e 461 (fragment I) and m/e 173 (fragment 
II) are due to fission of the 20-22 bond with the 
charge located on either the large or the small frag 
ment (see insert of fig.3). The fragments at m/e 371 
and m/e 281 are formed from fragment I by losing 
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one or two (CHa)s Si-OH groups respectively. Analogous 
to this fragment II will give a peak at m/e 83. The 
peak at m/e 117 could be explained by production of 
another small fragment by cleavage of the Cl 7-20 
bond in fragment I after hydrogen transfer from the 
steroid skeleton with the charge remaining at the 
C-20 site. Cleavage of the total side-chain is responsible 
for the fragment at m/e 289; it will also lose one (CH& 
Si-OH group, yielding a peak at m/e 199. 
The lower mass spectrum in fig.3 is that of the 
biological intermediate and compares extremely well 
with the upper spectrum. From these spectra and the 
gaschromatogram the conclusion is justified that the 
intermediate is 2Oq 22R-d&OH cholesterol. The mass 
spectrum is similar to the spectrum from the same 
compound isolated from meconium [ 131 with slight 
changes for the underivatised 20~OH group. 
Volume 54, number 2 FEBS LETTERS June 1975 
4. Discussion 
According to the experiments described an inter- 
mediate between 22R and 20a, 22R must be present 
when 22R is converted into pregnenolone and 
isocaproaldehyde. A peroxide as a physiological 
intermediate is highly improbable. All tests on 
peroxides as described in Feigl [ 141 and Stahl [ 1.51 
indicated the presence of only traces of peroxides. In 
addition, the concentration of these trace amounts 
did not vary significantly in time. 
The following evidence strongly suggests that an 
epoxide is an intermediate. 
1. Both chemical (HC104) and enzymatic hydrolysis 
(fig.l-A, I-B) yield 20,22-di-OH cholesterol. 
2. l8 0 from Hz ‘*O is incorporated in 2Oo, 22R with 
22R as starting product [6]. Assuming 20,22-epoxy- 
cholesterol is an intermediate in the side-chain 
cleavage reaction this could easily be explained. It 
is incompatible with the consecutive or concerted 
action of two hydroxylases (mono-oxygenases). 
3. Epoxides can react with silylation agents in the 
following way [ 161 : 
‘c’ \/ C- 0-TMSi 
‘0 + TMSi-X + / 
C/ 
/\ 
c-x 
/\ 
(X = Cl, N-methylacetamide, imidazole) 
The products of such silylation reactions are known 
to have low volatility [ 171 . Thus on considering the 
reaction between 20,22-epoxycholesterol and trimethyl- 
silylimidazole one would expect a similar derivative, 
unsuitable for gas chromatography owing to its low 
volatility. 
It can be seen that under the conditions of exp. 
1-A the epoxy-hydrase is rate limiting. In the presence 
of > 99% CO (fig. 1 -B) neither is an epoxide formed 
nor is 2001, 22R converted; however the epoxy-hydrase 
is able to catalyze the conversion of 20,22-epoxy- 
cholesterol into 200, 22R. The following explanation 
can now be given. The conversion of 2Oo, 22R into 
pregnenolone is known to require NADPH and 0, ; 
cytochrome P-450 is involved and the reaction is 
inhibited by CO [ 18,191. Epoxidation of double 
bonds in the liver is also known to be cytochrome 
P-450- or P-448-dependent; NADPH and @ are 
, CHOLESTEROL 
NADPH+H++O, 
NADP++ H20 
, CHOLESTEROL 
, CHOLESTEROL 
COm 
b + Hh 
PREGNENOLONE ISOCAPROALDEHYDE 
required [20-221. By analogy one could therefore 
expect in exp. 1-B both the formation of the cholesterol 
epoxide and the conversion of 2Oo, 22R to be inhibited 
by CO. The data obtained support our recently 
proposed hypothesis [6] concerning cholesterol side- 
chain cleavage (fig.5). 
One might expect 20a-OH cholesterol to behave in 
a manner similar to 22R, since conversion of the 
sterol in the presence of Ha la0 gave rise to “0 
containing pregnenolone [6]. However the phenomena 
shown in fig. 1-A have not been found with 2Oar as a 
substrate (unpublished experiments, R. J. Kraaipoel), 
probably because the conversion 2Oar + A2o-22 is 
slower than 22R + A20-22. The epoxy-hydrase reaction 
therefore is no longer the rate limiting step. It is also 
possible to explain the different behaviour of 2Oo and 
22R with respect to the apparent ‘mass-defect’ by 
postulating the formation of two different epoxides 
(2Oo, 22a-epoxycholesterol and 2Op, 22(3-epoxy- 
cholesterol). This would agree with our earlier suggestior 
177 
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2o-22 [6] that n cholesterol originating from 2Oa is clearly an area that requires further research and 
attached to the enzyme surface in a stereochemically elucidation. 
20-22 different way than n cholesterol originating from 
22R. 
It is of some interest that several epoxy-hydrases 
have been described [22,23]. Recently it was reported 
that 5a, 6a-epoxy-cholesterol, a known carcinogen, is 
formed continuously in the skin under the influence 
of light. It is transformed by a 5a, 6cu-epoxy-hydrase 
into cholestane-30, ICY, 6/3-trio1 241. 
Acknowledgements 
Burstein et al. [25], using acetone extracted bovine 
adrenal cortex mitochondria, tentatively identified 
2001, 22R as an intermediate by recrystallisation 
techniques. This has now been confirmed by our 
experiments. The time course of their reaction [ 1,2], 
using this material, was similar to the one shown in 
fig.l-B but no ‘mass-defect’ was found. An explanation 
for the discrepancy was found when we used mitochon 
drial preparations stored under poor conditions (the 
storage container was not refilled in time with liquid 
nitrogen). A conversion of 22R into pregnenolone 
according to fig.l-B was repeatedly demonstrated. We 
found earlier that the enzymatic conversion of DOCK, 
22R into pregnenolone and isocaproaldehyde is very 
susceptible to inhibition. Contact with air when 
mitochondria are in a freeze-dried condition also 
selectively damages this last step [6]. The epoxy- 
hydrase is no longer rate limiting and thus no epoxide 
but 2Ory, 22R accumulates. This may be the reason 
why some investigators found 20a, 22R as an 
intermediate and others did not. 
Mrs Mary Amesz-Heinrich, Mr A. A. M. Kempers 
and Dr D. A. Price are gratefully acknowledged for 
their help with the preparation of the manuscript. 
Cyanoketone was a gift from Sterling-Winthrop. This 
work was supported by a grant from the Netherlands 
Foundation for Fundamental Medical Research. 
References 
111 
I21 
131 
141 
I51 
161 
It is tempting to speculate about the four enzymatic 
activities, needed to convert cholesterol into pregneno- 
lone. According to our scheme these are an oxidative 
desaturase [26], an epoxidase, an epoxy-hydrase and 
a lyase (desmolase). We suggest hat the epoxidase and 
lyase activities belong to the group of cytochromes 
P-450. It is interesting to compare this with the 
cytochrome P-450 preparation isolated by Shikita and 
Hall [27,28], containing 8 heme groups per molecule 
P-450. It appears that this adrenocortical P-450 
(mol. wt 850 000) is isolated in a form consisting of 
16 subunits and can exist in forms of 8 (mol. wt 
470 000) and 4 (mol. wt 200 000) subunits. Drastic 
treatments result in the formation of single units. The 
fragment of 4 subunits (after addition of the specific 
flavoprotein and non-heme iron protein) was still able 
to convert cholesterol into pregnenolone [ 191. This is 
I71 
[81 
191 
I101 
[111 
[I21 
[I31 
1141 
Burstein, S., Kimball, H. L. and Gut, M. (1970) Steroids 
15, 8099857. 
Burstein, S. and Gut, M. (1971) Recent Progress in 
Hormone Research 27, 3033349. 
Van Lier, J. E. and Smith, L. L. (1970) Biochim. 
Biophys. Acta 210. 153-163. 
Van Lier, J. E. and Smith, L. L. (1970) Biochem. 
Biophys. Res. Commun. 40, 5 10-S 16. 
Luttrell, B., IIochberg, R. B., Dixon, W. R., McDonals, P. D. 
and Lieberman, S. (1972) J. Biol. Chem. 247, 1462-1472. 
Kmaipoel, R. J., Degenhart, H. J., Leferink, J. G., 
Van Beek, V., de Leeuw-Boon, H. and Visser. H. K. A. 
(1975) FEBS Lett. 50, 204-209. 
Goldman, A. S. (1967) J. Clin. Endocr. 27, 325-332. 
Rutten, G. A. 1;. M. and Luyten, J. A. (1972) J. 
Chromatogr. 74, 177-181. 
Van den Berg, P. M. J. and Cox, Th. P. H. (1972) 
Chromatographia 5, 301-305. 
Leferink, J. G. and Leclercq, P. A. (1974) J. Chromatogr. 
91,385-391. 
Chaudhuri, N. K., Nickolson, R., Kimball, H. L. and 
Gut, M. (1970) Steroids 15, 525-539. 
Fieser, L. F. and Fieser, M. (1967) Reagents for Organic 
Synthesis, p. 796, John Wiley and Sons, Inc. New York, 
London, Sydney. 
Eneroth, P. and Gustafsson, J. A. (1969) FEBS Lett. 5, 
999103. 
Feigl. F. (1971) Spot Tests in Organic Analysis, 7th 
Engl. Edn. Elsevier Publ. Comp., Amsterdam, London, 
New York. 
[I51 
[I61 
I171 
[I81 
Stahl, E. (1967) Dtinnschicht Chromatographie, zweite 
Auflage Springer Verlag, Berlin, Heidelberg, New York. 
Birkofer, L., Dickopp, H. (1969) Chem. Ber. 102, 14-22. 
Stoming, T., Knapp, D. and Bresnick, E. (1973) Life Sci. 
12,425-429. 
Shimizu, K. (1968) Arch. Biochem. Biophys. 125, 
1016-1017. 
178 
Volume 54, number 2 FEBS LETTERS June 1975 
[ 191 Shikita, M. and Hall, P. F. (1974) Proc. Natl. Acad. Sci. (231 Breuer, H. and Knuppen, R. (1961) Biochim. Biophys. 
U.S.A. 71, 1441-1445. Acta 49, 620-621. 
[ 20) Brodie, B. B., Reid. W. D., Cho. A. K., Sipes, G., [24] Chan, J. T. and Black, H. S. (1974) Science 186, 
Krishna, G. and Gillette, J. R. (1971) Proc. Natl. Acad. 1216-1217. 
Sci. U.S.A. 68, 160-164. [25] Burstein, S., Zamoscianyk, H., Kimball, H. L., 
(211 Jerina, D. M., Daly, J. M., Witkop, B., Zaltzman-Nirenberp, P. Chaudhuri, N. K. and Gut, M. (1970) Steroids 15, 
and Udenfriend, S. (1970) Biochemistry 9, 147-155. 13-60. 
1221 Dansette, P. M., Yagi, H., Daly, J. W., Levin, W., [261 Fulco, A. J. (1974) Ann. Rev. Biochem. 43. 215-241. 
Lu, A. Y. H., Kuntzman, R. and Conney, A. H. (1974) [27] Shikita, M. and Hall, P. F. (1973) J. Biol. Chem. 248, 
Arch. Biochem. Biophys. 164, 5 11-S 17. 5598-5604. 
[281 Shikita, M. and Hall, P. F. (1973) J. Biol. Chem. 248, 
5605-5609. 
179 
